Pramocaine

Basic Information

Item Value
DrugBank ID DB09345
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 37

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 papillary conjunctivitis KG + DL
2 acne keloid KG + DL
3 acrodermatitis chronica atrophicans KG + DL
4 neonatal dermatomyositis KG + DL
5 vernal conjunctivitis KG + DL
6 hydroa vacciniforme, familial KG + DL
7 secondary interstitial lung disease specific to childhood associated with a connective tissue disease KG + DL
8 amyopathic dermatomyositis KG + DL
9 atopic conjunctivitis KG + DL
10 rosacea conjunctivitis KG + DL
11 infectious anterior uveitis KG + DL
12 anorectal stricture KG + DL
13 pityriasis versicolor KG + DL
14 cutaneous candidiasis KG + DL
15 pityriasis simplex KG + DL
16 anal polyp KG + DL
17 postinfectious vasculitis KG + DL
18 post-bacterial disorder KG + DL
19 post-infectious syndrome KG + DL
20 infection-related hemolytic uremic syndrome KG + DL
21 Chagas cardiomyopathy KG + DL
22 infective urethral stricture KG + DL
23 blepharoconjunctivitis KG + DL
24 atopic eczema KG + DL
25 dermatitis, atopic KG + DL
26 imperforate anus KG + DL
27 neurodermatitis KG + DL
28 ulcerative blepharitis KG + DL
29 parasitic eyelid infestation KG + DL
30 conjunctival folliculosis KG + DL
31 serous conjunctivitis except viral KG + DL
32 parasitic conjunctivitis KG + DL
33 chronic follicular conjunctivitis KG + DL
34 acute hemorrhagic conjunctivitis KG + DL
35 noninfectious dermatoses of eyelid KG + DL
36 Angelucci syndrome KG + DL
37 pseudomembranous conjunctivitis KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.